PTH and chronic kidney disease: The case reports noted increased bone turnover and bone volume or BMD after 8 to 24 months of teriparatide given to 4 patients with biopsy‐proven ABD.17, 18, 19, 20 Cejka and colleagues11 administered teriparatide for ≤6 months to 7 CKD patients with ABD based on PTH <100 pg/mL (n = 6) or bone biopsy (n = 1).